A rare case of symptomatic grossly-visible biliary intraepithelial neoplasia mimicking cholangiocarcinoma.


Journal

World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544

Informations de publication

Date de publication:
11 Nov 2019
Historique:
received: 04 08 2019
accepted: 29 10 2019
entrez: 13 11 2019
pubmed: 13 11 2019
medline: 28 4 2020
Statut: epublish

Résumé

Biliary intraepithelial neoplasia (BilIN) is often distinguished by what it is not: the precancerous lesions are not mass-forming, are not the cause of bile duct obstruction, and are small enough (less than 5 mm long) to evade detection by the naked eye. Here, we describe an atypical case of BilIN resembling cholangiocarcinoma (CC) that was large enough to be identified by diagnostic imaging and presented with obstructive jaundice caused by a hematoma in the common bile duct (CBD). A 64-year-old man presented to our hospital with upper abdominal pain and anorexia. Initial laboratory examinations revealed increased total bilirubin and a computed tomography (CT) scan revealed a dilated CBD. Gastroenterologists performed an endoscopic sphincterotomy (EST), which revealed that the cause of obstructive jaundice was a hematoma in the CBD. Enhanced CT scan and magnetic resonance cholangiopancreatography (MRCP) performed after the hematoma was drained showed improved dilation of the CBD and an enhanced wall thickness of bile duct measuring 25 × 10 mm at the union of the cystic and common hepatic ducts. A cholangioscope detected an elevated tumor covered by sludge in the CBD, and we performed an extrahepatic bile duct resection and cholecystectomy. The postoperative course was uneventful and the pathological examination of the resected tumor revealed that although the ulcerated lesion had inflammatory granulation tissue, it did not contain the components of invasive carcinoma. Many consecutive intraepithelial micropapillary lesions spread around the ulcerated lesion, and the epithelial cells showed an increased nucleus-to-cytoplasm ratio, nuclear hyperchromasia, and architectural atypia. The pathological diagnosis was BilIN-1 to -2. Immunohistochemical staining showed that S100P was slightly expressed and MUC5AC was positive, while MUC1 was negative and p53 was not overexpressed. We experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the CBD. Our case suggested that the occurrence of BilIN can be triggered by factors other than inflammation, and can grow to a size large enough to be detected by image analyses.

Sections du résumé

BACKGROUND BACKGROUND
Biliary intraepithelial neoplasia (BilIN) is often distinguished by what it is not: the precancerous lesions are not mass-forming, are not the cause of bile duct obstruction, and are small enough (less than 5 mm long) to evade detection by the naked eye. Here, we describe an atypical case of BilIN resembling cholangiocarcinoma (CC) that was large enough to be identified by diagnostic imaging and presented with obstructive jaundice caused by a hematoma in the common bile duct (CBD).
CASE PRESENTATION METHODS
A 64-year-old man presented to our hospital with upper abdominal pain and anorexia. Initial laboratory examinations revealed increased total bilirubin and a computed tomography (CT) scan revealed a dilated CBD. Gastroenterologists performed an endoscopic sphincterotomy (EST), which revealed that the cause of obstructive jaundice was a hematoma in the CBD. Enhanced CT scan and magnetic resonance cholangiopancreatography (MRCP) performed after the hematoma was drained showed improved dilation of the CBD and an enhanced wall thickness of bile duct measuring 25 × 10 mm at the union of the cystic and common hepatic ducts. A cholangioscope detected an elevated tumor covered by sludge in the CBD, and we performed an extrahepatic bile duct resection and cholecystectomy. The postoperative course was uneventful and the pathological examination of the resected tumor revealed that although the ulcerated lesion had inflammatory granulation tissue, it did not contain the components of invasive carcinoma. Many consecutive intraepithelial micropapillary lesions spread around the ulcerated lesion, and the epithelial cells showed an increased nucleus-to-cytoplasm ratio, nuclear hyperchromasia, and architectural atypia. The pathological diagnosis was BilIN-1 to -2. Immunohistochemical staining showed that S100P was slightly expressed and MUC5AC was positive, while MUC1 was negative and p53 was not overexpressed.
CONCLUSION CONCLUSIONS
We experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the CBD. Our case suggested that the occurrence of BilIN can be triggered by factors other than inflammation, and can grow to a size large enough to be detected by image analyses.

Identifiants

pubmed: 31711502
doi: 10.1186/s12957-019-1737-y
pii: 10.1186/s12957-019-1737-y
pmc: PMC6849222
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191

Références

Pathol Int. 2005 Apr;55(4):180-8
pubmed: 15826244
Virchows Arch. 2015 Feb;466(2):133-41
pubmed: 25425476
Cancer. 2005 Mar 15;103(6):1210-6
pubmed: 15685618
J Gastroenterol. 2014 Jan;49(1):64-72
pubmed: 23616173
Liver Int. 2019 May;39 Suppl 1:7-18
pubmed: 30882996
Korean J Hepatol. 2011 Dec;17(4):328-30
pubmed: 22310799
Hepatology. 1996 Nov;24(5):1074-8
pubmed: 8903378
Int J Hepatol. 2014;2014:678260
pubmed: 24860672
Arch Pathol Lab Med. 2016 May;140(5):429-36
pubmed: 27128300
Mod Pathol. 2007 Jun;20(6):701-9
pubmed: 17431410
Hepat Mon. 2016 Dec 14;16(12):e38726
pubmed: 28123440
World J Surg. 2007 Sep;31(9):1788-96
pubmed: 17647056
World J Surg Oncol. 2009 Dec 05;7:93
pubmed: 19961613
Oncol Lett. 2016 May;11(5):3142-3144
pubmed: 27123079
Oncol Rep. 2009 Sep;22(3):649-57
pubmed: 19639217
Arch Pathol Lab Med. 2016 Nov;140(11):1285-1289
pubmed: 27788047
Hum Pathol. 2017 Feb;60:46-57
pubmed: 27984121
Clin J Gastroenterol. 2012 Jun;5(3):189-94
pubmed: 26182319
Pathol Int. 2011 Aug;61(8):481-5
pubmed: 21790863
Histopathology. 2018 Aug;73(2):247-258
pubmed: 29660164
Pathol Oncol Res. 2018 Nov 17;:null
pubmed: 30448973
Virchows Arch. 2010 Jun;456(6):711-7
pubmed: 20428886
J Hepatol. 2006 Feb;44(2):350-8
pubmed: 16360234
Hum Pathol. 2008 Aug;39(8):1153-61
pubmed: 18495210

Auteurs

Naohiro Yoshida (N)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan. yoshida_naohiro@med.kurume-u.ac.jp.

Takeshi Aoyagi (T)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Yoshizo Kimura (Y)

Department of Pathology and Cytology, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Yoshiki Naito (Y)

Department of Pathology, Kurume University School of Medicine, Asahi-machi 67, Kurume-shi, Fukuoka, 8300011, Japan.

Aya Izuwa (A)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Kimihisa Mizoguchi (K)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Kota Ishii (K)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Yu Tanaka (Y)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Emi Ohnishi (E)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Shun Miura (S)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Satoshi Shimamura (S)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Nobuhisa Shirahama (N)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Kazuhisa Kaneshiro (K)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Akihiro Saruwatari (A)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Ayako Iwanaga (A)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Yoshihiko Sadakari (Y)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Gentaro Hirokata (G)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Toshiro Ogata (T)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Masahiko Taniguchi (M)

Department of Surgery, St. Mary's Hospital, Tsubukuhon-machi 422, Kurume-shi, Fukuoka, 8308543, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH